Cargando…

Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants

Since discovering that ketamine has robust antidepressant effects, the glutamatergic system has been proposed as an attractive target for the development of novel antidepressants. Among the glutamatergic system, metabotropic glutamate (mGlu) receptors are of interest because mGlu receptors play modu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaki, Shigeyuki, Koike, Hiroyuki, Fukumoto, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243201/ https://www.ncbi.nlm.nih.gov/pubmed/32500107 http://dx.doi.org/10.1177/2470547019837712

Ejemplares similares

Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2015)

Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
por: Yasuhara, Akito, et al.
Publicado: (2010)

Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
por: Chaki, Shigeyuki, et al.
Publicado: (2019)

Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
por: Maksymetz, James, et al.
Publicado: (2017)

Role of 5-HT(1A) Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine
por: Fukumoto, Kenichi, et al.
Publicado: (2017)

Vasopressin V(1B) Receptor Antagonists as Potential Antidepressants
por: Chaki, Shigeyuki
Publicado: (2021)

Therapeutic promise and principles: Metabotropic glutamate receptors
por: Maiese, Kenneth, et al.
Publicado: (2008)

Metabotropic Glutamate Receptors as Novel Therapeutic Targets on Visceral Sensory Pathways
por: Blackshaw, L. Ashley, et al.
Publicado: (2011)

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016)

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas
por: Pereira, Mery Stefani Leivas, et al.
Publicado: (2017)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021)

Safety and pharmacokinetic profiles of MGS0274 besylate (TS‐134), a novel metabotropic glutamate 2/3 receptor agonist prodrug, in healthy subjects
por: Watanabe, Mai, et al.
Publicado: (2020)

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease
por: Luessen, Deborah J., et al.
Publicado: (2022)

Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)

The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Metabotropic Glutamate Receptors at Ribbon Synapses in the Retina and Cochlea
por: Klotz-Weigand, Lisa, et al.
Publicado: (2022)

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors
por: Mazzitelli, Mariacristina, et al.
Publicado: (2022)

Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013)

Kinetic fingerprinting of metabotropic glutamate receptors
por: Kukaj, Taulant, et al.
Publicado: (2023)

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
por: Domanegg, Kevin, et al.
Publicado: (2023)

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression
por: Eddy, Kevinn, et al.
Publicado: (2022)

Metabotropic glutamate receptor 5: a target for migraine therapy
por: Waung, Maggie W., et al.
Publicado: (2016)

Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors
por: Llinas del Torrent, Claudia, et al.
Publicado: (2019)

Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update
por: Mao, Li-Min, et al.
Publicado: (2022)

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
por: Chaki, Shigeyuki
Publicado: (2017)

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
por: Duty, Susan
Publicado: (2010)

Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer
por: Speyer, Cecilia L., et al.
Publicado: (2014)

Structural Insights into Metabotropic Glutamate Receptor Activation
por: Koehl, Antoine, et al.
Publicado: (2019)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
por: Crupi, Rosalia, et al.
Publicado: (2019)

Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
por: Hovelsø, N, et al.
Publicado: (2012)

Homology modelling of metabotropic glutamate receptor 2
por: Mordalski, S, et al.
Publicado: (2011)

Constitutive activity of metabotropic glutamate receptor 7
por: Kammermeier, Paul J
Publicado: (2015)

Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis
por: Qian, Feng, et al.
Publicado: (2016)

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
por: Maj, Carlo, et al.
Publicado: (2016)

Special Issue on Metabotropic Glutamate Receptors: Editorial
por: Salt, Prof. Thomas E.
Publicado: (2016)

Metabotropic glutamate receptor 5 in bulimia nervosa
por: Mihov, Yoan, et al.
Publicado: (2020)

Allosteric Molecular Switches in Metabotropic Glutamate Receptors
por: Orgován, Zoltán, et al.
Publicado: (2020)

Mechanisms of differential desensitization of metabotropic glutamate receptors
por: Abreu, Nohely, et al.
Publicado: (2021)

Metabotropic glutamate receptor dependent long-term depression in the cortex
por: Kang, Sukjae Joshua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6nba5ske1n1eaelaplrgg5sfhi